Today, November 25, 2016 AcouSort released its Q3-2016 financial report. Link to the full report may be found here: AcouSort-Q3-2016
Highlights from the report are:
First nine months (2016-01-01 to 2016-09-30)
- Revenues KSEK 1,723 (1,308)
- Profits before tax KSEK 51 (63)
Third Quarter (2016-01-07 to 2016-09-30)
- Revenues KSEK 762 (496)
- Profits before tax KSEK 134 (154)
In order to comply with formal requirements becoming a listed company, AcouSort conducted in September an internal new share emission increasing the share capital with SEK 490,000.
Other significant results from third quarter include the conclusion of a phase III technology development project targeting an OEM blood/plasma separation module. The Company further signed a Collaboration Agreement with a second potential OEM customer for the conduction of a phase I feasibility study. Finally, the Company completed the development of AcouTrap bench top system version 2.1 being the first commercial version of the system.